Global Myasthenia Gravis Market share 2020 Forecast Analysis by 2027

Posted by shriya on June 8th, 2021

Myasthenia Gravis Market: By Type (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis, Transient Myasthenia Gravis and Others), (Diagnosis and Treatment), End User (Hospitals and Clinics, Diagnostic Centers and Academic and Research Organizations) and By Region-Global Forecast Till 2027


The latest study conducted by Market Research Future (MRFR) reveals the global myasthenia gravis market share is set to witness 9.61% CAGR during the assessment period (2018-2023) and surpass a valuation of USD 3,000 Mn.  Factors such as increased prevalence rate, investment in R&D and advances in healthcare are likely to support the growth of the market. In recent years, a sharp rise in MG and related incidences has been noticed. 

Segmental Analysis

The report includes a segmental analysis of the market, which covers disease type, end-user, diagnosis and treatment and region. By type, the market has been segmented into congenital myasthenia gravis, transient myasthenia gravis, ocular myasthenia gravis, generalized myasthenia gravis and others. The generalized myasthenia gravis segment accounts for the dominant share of the market. 

Regional Analysis

The regions that are covered in the report are Europe, Americas, Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, Americas captured the largest market share in terms of value. The region is likely to retain its dominance over the review period. There are several factors that can be linked with the region superior position, the prominent ones being existence of a world-class healthcare system, particularly in countries such as the U.S. and Canada, rising healthcare spending and availability of a wide rang of treatment options.

Myasthenia Gravis Market: Competitive Landscape

Global players mentioned in MRFR’s report include GE Healthcare, Novartis AG, Boston Scientific Corporation, Grifols S.A., Koninklijke Philips N.V., Alexion Pharmaceuticals, Inc. Valeant Pharmaceuticals International, Inc., Pfizer Inc., Medtronic Plc., Shire, CSL Behring and Baxter.

Browse Detailed TOC with COVID-19 Impact Analysis at:


Akash Anand

Market Research Future

+1 646 845 9312


Like it? Share it!


About the Author

Joined: May 18th, 2021
Articles Posted: 81

More by this author